(RTTNews) – Shares of UniQure (QURE) tanked nearly 20% in morning trade on Thursday. The company a day ago announced that CSL Behring (CSL) would acquire exclusive commercialization rights to its gene-therapy program.

CSL Behring will acquire exclusive global license rights to commercialize an adeno-associated virus (AAV) gene therapy program,…